Literature DB >> 11595727

Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.

G Davies1, W G Jiang, M D Mason.   

Abstract

PURPOSE: The current study examined the effects of hepatocyte growth factor/scatter factor (HGF/SF) on cell-cell dissociation, invasion, and its association with the mediated release of matrix metalloproteinase-7 (Matrilysin) on the extracellular cleavage of E-cadherin in prostate cancer cells. EXPERIMENTAL
DESIGN: The effects of HGF/SF on cell-cell dissociation, in vitro invasion, and on the expression of E-cadherin at both protein and mRNA levels were assessed in cells whose expression of Matrilysin was altered by treatment with antisense oligonucleotide.
RESULTS: Incubation with HGF/SF mediated the release of active Matrilysin (M(r) 19,000), resulting in extracellular cleavage of E-cadherin from prostate cancer cells. This resultant soluble M(r) 80,000 fragment of E-cadherin was subsequently recognized upon immunoprobing with an anti-E-cadherin antibody. Both recombinant human Matrilysin (rh-Matrilysin) and/or HGF/SF increased the level of soluble E-cadherin and decreased the level of full-length (M(r) 120,000) E-cadherin as detected by Western blotting. The effects of rh-Matrilysin and HGF/SF were inhibited by an antisense oligonucleotide specifically directed toward human Matrilysin. In addition, stimulation with either rh-Matrilysin or HGF/SF resulted in disruption to the E-cadherin/beta-catenin complex, as shown by a significant increase (P < 0.05) in both cell scattering and invasion index.
CONCLUSIONS: Treatment with HGF/SF induced Matrilysin-mediated cleavage to the extracellular domain of E-cadherin, resulting in its dissociation from the cadherin/catenin complex. This provides a new mechanism in HGF/SF-induced cell scattering, resulting in a switch to a more invasive phenotype in LNCapFGC cells, as demonstrated by in vitro invasion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595727

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  46 in total

Review 1.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

2.  A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.

Authors:  Giuseppe Pelosi; Aldo Scarpa; Giulia Veronesi; Lorenzo Spaggiari; Barbara Del Curto; Patrick S Moore; Patrick Maisonneuve; Angelica Sonzogni; Michele Masullo; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

Review 3.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.

Authors:  Megumi Iiizumi; Wen Liu; Sudha K Pai; Eiji Furuta; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2008-07-22

4.  Life after proteolysis: Exploring the signaling capabilities of classical cadherin cleavage fragments.

Authors:  Catherine D McCusker; Dominique Alfandari
Journal:  Commun Integr Biol       Date:  2009

5.  Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription.

Authors:  Fei-Yan Pan; Sheng-Zhou Zhang; Na Xu; Fan-Li Meng; Hong-Xia Zhang; Bin Xue; Xiao Han; Chao-Jun Li
Journal:  Histochem Cell Biol       Date:  2010-07-31       Impact factor: 4.304

6.  NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.

Authors:  Takeshi Kubota; Hiroaki Taiyoh; Atsushi Matsumura; Yasutoshi Murayama; Daisuke Ichikawa; Kazuma Okamoto; Hitoshi Fujiwara; Hisashi Ikoma; Masayoshi Nakanishi; Shojiro Kikuchi; Chouhei Sakakura; Toshiya Ochiai; Yukihito Kokuba; Hiroki Taniguchi; Teruhisa Sonoyama; Kunio Matsumoto; Toshikazu Nakamura; Eigo Otsuji
Journal:  Clin Exp Metastasis       Date:  2009-02-21       Impact factor: 5.150

Review 7.  Soluble cadherins as cancer biomarkers.

Authors:  Olivier De Wever; Lara Derycke; An Hendrix; Gert De Meerleer; François Godeau; Herman Depypere; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

8.  MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis.

Authors:  Helen Williams; Jason L Johnson; Christopher L Jackson; Stephen J White; Sarah J George
Journal:  Cardiovasc Res       Date:  2010-02-05       Impact factor: 10.787

9.  Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.

Authors:  S M Brouxhon; S Kyrkanides; X Teng; M Athar; S Ghazizadeh; M Simon; M K O'Banion; L Ma
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

10.  Soluble E-cadherin: an early marker of severity in acute pancreatitis.

Authors:  A Sewpaul; J J French; T K Khoo; M Kernohan; J A Kirby; R M Charnley
Journal:  HPB Surg       Date:  2009-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.